Globe Life Inc. (NYSE:GL) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Globe Life Inc. (NYSE:GL) have earned an average recommendation of “Moderate Buy” from the eleven ratings firms that are currently covering the company, Marketbeat reports. Two equities research analysts have rated the stock with a hold recommendation, eight have given a buy recommendation and one has issued a strong buy recommendation on the company. The average twelve-month target price among analysts that have issued ratings on the stock in the last year is $171.3333.

Several research analysts have weighed in on the company. Truist Financial upped their target price on Globe Life from $158.00 to $180.00 and gave the stock a “buy” rating in a research report on Friday, February 6th. TD Cowen reiterated a “buy” rating on shares of Globe Life in a report on Thursday, December 11th. JPMorgan Chase & Co. boosted their price target on Globe Life from $180.00 to $181.00 and gave the company an “overweight” rating in a research note on Thursday, February 5th. Morgan Stanley restated an “overweight” rating and issued a $176.00 price objective on shares of Globe Life in a report on Monday, December 15th. Finally, Weiss Ratings raised shares of Globe Life from a “hold (c+)” rating to a “buy (b-)” rating in a research report on Friday, February 13th.

Insider Buying and Selling at Globe Life

In related news, CEO Frank M. Svoboda sold 12,500 shares of Globe Life stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $144.78, for a total value of $1,809,750.00. Following the completion of the sale, the chief executive officer owned 35,868 shares of the company’s stock, valued at approximately $5,192,969.04. The trade was a 25.84% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Mark A. Blinn sold 1,750 shares of the company’s stock in a transaction on Friday, February 6th. The stock was sold at an average price of $147.91, for a total transaction of $258,842.50. Following the completion of the sale, the director owned 3,372 shares of the company’s stock, valued at $498,752.52. This represents a 34.17% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders have sold 82,807 shares of company stock worth $12,041,286 in the last ninety days. Company insiders own 1.51% of the company’s stock.

Institutional Trading of Globe Life

Several large investors have recently made changes to their positions in the stock. Compound Planning Inc. increased its holdings in shares of Globe Life by 4.3% during the 4th quarter. Compound Planning Inc. now owns 1,968 shares of the company’s stock valued at $275,000 after acquiring an additional 82 shares during the last quarter. Transcend Capital Advisors LLC lifted its holdings in Globe Life by 3.9% in the 4th quarter. Transcend Capital Advisors LLC now owns 2,265 shares of the company’s stock worth $317,000 after purchasing an additional 84 shares during the last quarter. Natural Investments LLC boosted its position in Globe Life by 2.6% during the fourth quarter. Natural Investments LLC now owns 3,452 shares of the company’s stock worth $482,000 after purchasing an additional 87 shares during the period. Parallel Advisors LLC boosted its position in Globe Life by 5.6% during the fourth quarter. Parallel Advisors LLC now owns 1,651 shares of the company’s stock worth $231,000 after purchasing an additional 87 shares during the period. Finally, CX Institutional grew its holdings in Globe Life by 5.6% during the third quarter. CX Institutional now owns 1,805 shares of the company’s stock valued at $258,000 after purchasing an additional 96 shares during the last quarter. Institutional investors own 81.61% of the company’s stock.

Globe Life Trading Down 0.7%

Globe Life stock opened at $137.56 on Thursday. Globe Life has a 12 month low of $109.38 and a 12 month high of $152.71. The company has a quick ratio of 0.07, a current ratio of 0.07 and a debt-to-equity ratio of 0.39. The stock has a market cap of $10.79 billion, a P/E ratio of 9.77 and a beta of 0.46. The company’s fifty day simple moving average is $141.54 and its 200-day simple moving average is $138.89.

Globe Life (NYSE:GL) last announced its quarterly earnings data on Wednesday, February 4th. The company reported $3.39 earnings per share (EPS) for the quarter, missing the consensus estimate of $3.44 by ($0.05). The firm had revenue of $1.52 billion for the quarter, compared to analysts’ expectations of $1.53 billion. Globe Life had a return on equity of 21.30% and a net margin of 19.37%.Globe Life’s revenue was up 3.6% on a year-over-year basis. During the same quarter in the prior year, the business posted $3.14 earnings per share. Globe Life has set its FY 2026 guidance at 14.950-15.650 EPS. As a group, sell-side analysts forecast that Globe Life will post 13.87 EPS for the current fiscal year.

Globe Life Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 1st. Stockholders of record on Friday, April 3rd will be paid a dividend of $0.33 per share. This is a positive change from Globe Life’s previous quarterly dividend of $0.27. The ex-dividend date is Thursday, April 2nd. This represents a $1.32 annualized dividend and a dividend yield of 1.0%. Globe Life’s dividend payout ratio (DPR) is currently 7.67%.

About Globe Life

Globe Life, traded on the NYSE under the symbol GL, is a U.S.-based insurance holding company that underwrites and distributes a range of life and supplemental health insurance products. Through its subsidiary brands—Globe Life, American Income Life, Liberty National Life, United American Insurance Company and Family Heritage Life—it offers term life, whole life, fixed annuities and supplemental health coverage designed to meet the needs of individuals and families across various socioeconomic segments.

The company’s product suite includes low-cost, easy-to-understand life insurance policies, accidental death and dismemberment coverage, hospital indemnity plans and specified disease insurance.